Is ALNY or HUM cheaper?

On trailing earnings, HUM is cheaper: ALNY trades at a 63.53 P/E and HUM at 42.59.

Which has grown faster, ALNY or HUM?

Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus HUM at 11.71%.

Does ALNY or HUM pay a bigger dividend?

HUM pays a dividend (0.89% yield) while ALNY does not currently pay one.

Is ALNY or HUM more profitable?

ALNY runs the higher net margin — ALNY at 13.46% versus HUM at 0.82%.

Which has been the better investment, ALNY or HUM?

Over the past 10-year, ALNY delivered the higher annualized total return — ALNY at 15.31% versus HUM at 10.59%. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs Humana Inc. (HUM)

ALNY leads on 9 of 14 compared metrics, though HUM is the cheaper stock.

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

ALNY

Alnylam Pharmaceuticals, Inc.

$36.40B

$272.67HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT

HUM

Humana Inc.

$47.81B

$398.25HealthcareDelayed quote: Jul 20, 2026, 3:59 PM EDT

Total return — ALNY vs HUM

growth of $100 · dividends reinvested · last 22y

ALNY +4444.9%HUM +2560.7%ALNY compounded faster

ALNY HUM

ALNY vs HUM: by the numbers

•HUM is the larger company ($47.81B vs $36.40B market cap).
•HUM trades at the lower earnings multiple (42.59 vs 63.53 P/E).
•ALNY converts more revenue to profit (13.46% vs 0.82% net margin).
•ALNY grew revenue faster over the past five years (49.67% vs 11.71% CAGR).
•HUM pays a dividend (0.89% yield) while ALNY does not currently pay one.

Which is better, ALNY or HUM?

Metric tally: ALNY 9 · HUM 5

It depends on what you're optimizing for:

ValueHUM(lower P/E)

GrowthALNY(faster 5Y revenue CAGR)

QualityALNY(higher ROIC)

Metrics side by side

Valuation

Metric	ALNY	HUM
P/E ratio	63.53	42.59●
Forward P/E	35.91●	44.48
P/S ratio	8.62	0.35●
P/B ratio	34.38	2.59●
EV / EBITDA	45.27	26.10●
FCF yield	1.73%	2.65%●

Profitability

Metric	ALNY	HUM
Gross margin	80.89%●	14.01%
Operating margin	17.54%●	1.01%
Net margin	13.46%●	0.82%
ROE	53.68%●	6.08%
ROIC	13.74%●	3.12%

Dividends

Metric	ALNY	HUM
Dividend yield	—	0.89%
Payout ratio	—	35.87%

Growth (annualized)

Metric	ALNY	HUM
Revenue CAGR (5Y)	49.67%●	11.71%
EPS CAGR (5Y)	—	-17.27%
FCF CAGR (5Y)	14.35%●	-17.19%
Total return CAGR (5Y)	8.32%●	-1.89%

Frequently asked

Which is better, ALNY or HUM?: It depends on your goal. value: HUM (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: ALNY (higher ROIC). Across all compared metrics, ALNY leads 9 to 5.
Is ALNY or HUM cheaper?: On trailing earnings, HUM is cheaper: ALNY trades at a 63.53 P/E and HUM at 42.59.
Which has grown faster, ALNY or HUM?: Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus HUM at 11.71%.
Does ALNY or HUM pay a bigger dividend?: HUM pays a dividend (0.89% yield) while ALNY does not currently pay one.
Is ALNY or HUM more profitable?: ALNY runs the higher net margin — ALNY at 13.46% versus HUM at 0.82%.
Which has been the better investment, ALNY or HUM?: Over the past 10-year, ALNY delivered the higher annualized total return — ALNY at 15.31% versus HUM at 10.59%. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio Humana P/E ratio Alnylam Pharmaceuticals dividend yield Humana dividend yield Alnylam Pharmaceuticals ROE Humana ROE Alnylam Pharmaceuticals operating margin Humana operating margin Alnylam Pharmaceuticals revenue growth Humana revenue growth Alnylam Pharmaceuticals free cash flow Humana free cash flow

Alnylam Pharmaceuticals & Humana appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.